Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MLYS stock hub

Mineralys Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MLYSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.4B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MLYS

In the news

Latest news · MLYS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-31

P25 -105.6P50 -46.5P75 -3.1

ROIC-21.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MLYS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

USD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001933414
Company name	Mineralys Therapeutics, Inc.
Country	United States
Country code	US
Cusip	603170101
Employees	76
Employees Change	25%
Employees Change Percent	49.02
Enterprise value	$1.8B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2023-02-10
Isin	US6031701013
Last refreshed	2026-05-10
Market cap	$2.4B
Market cap category	Mid-Cap
Price	$29.54
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	MLYS
Website	https://mineralystx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.23%
FCF yield	-5.6%
P/B ratio	3.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-151.8M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Profit Per Employee	$-2M
ROA	-21.27
Roa5y	-64.6
ROCE	-26.87
ROE	-30.98
Roe5y	-356.5
ROIC	-21.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	100.23%
Cagr3y	23.53%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$652.9M
Cash	$646.1M
Current Assets	$652.5M
Current Liabilities	$14.7M
Equity	$638.1M
Liabilities	$14.7M
Long Term Assets	$392,000
Long Term Liabilities	$0
Net Cash	$646.1M
Net Cash By Market Cap	$26.51
Net Cash Growth	88.34%
Net Debt Equity	$-1.01
Tangible Book Value	$638.1M
Tangible Book Value Per Share	$7.74
WACC	6.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	44.33
Net Working Capital	$-8.3M
Quick ratio	43.9
Working Capital	$637.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-48.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	100.14%
200-day SMA	31.39
3Y total return	88.51%
50-day SMA	27.21
50-day SMA vs 200-day SMA	50under200
All Time High	47.65
All Time High Change	-38.01%
All Time High Date	2025-11-12
All Time Low	5.85
All Time Low Change	404.96%
All Time Low Date	2023-11-22
ATR	1.82
Beta	0.48
Beta1y	1.08
Beta2y	1.22
Ch YTD	-18.6
High	30
High52	47.65
High52 Date	2025-11-12
High52ch	-38.01%
Low	28.57
Low52	12.59
Low52 Date	2025-08-13
Low52ch	134.63%
Ma50ch	8.56%
Price vs 200-day SMA	-5.88%
RSI	56.69
RSI Monthly	57.75
RSI Weekly	50.19
Sharpe ratio	1.02x
Sortino ratio	3.09
Total Return	-48.35%
Tr YTD	-18.6
Tr1m	4.35%
Tr1w	0.96%
Tr3m	-0.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	4
Analyst Price Target Top	$53.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.45
Operating Income	$-171.5M
Price target	$48.67
Price Target Change	$64.76
Price Target Change Top	$81.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	60,359,044%
Float Percent	73.16%
Shares Insiders	0.81%
Shares Institutions	86.09%
Shares Out	82,498,101
Shares Qo Q	2.84%
Shares Yo Y	48.35%
Short Float	14.54%
Short Ratio	6.15
Short Shares	10.64

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-158.6M
Average Volume	1,098,871.45x
Bv Per Share	7.74
CAPEX	$-15,000
Ch1m	4.35
Ch1w	0.96
Ch1y	100.1
Ch3m	-0.77
Ch3y	88.51
Ch6m	-22.3
Change	0.65%
Change From Open	1.44
Close	29.35
Days Gap	-0.78
Depreciation Amortization	50,000
Dollar Volume	26,434,459.8
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$-171.5M
EBITDA	$-171.4M
EPS	$-2.02
F Score	2
FCF	$-136.4M
FCF EV Yield	-7.62x
FCF Per Share	$-1.65
Financing CF	425,992,000
Fiscal Year End	December
Founded	2,019
Investing CF	-341,820,000
Ipr	84.63
Iprfo	40
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	33.59
Ma150ch	-12.06%
Ma20	28.61
Ma20ch	3.27%
Net CF	-52,228,000
Next Earnings Date	2026-08-11
Open	29.12
Optionable	Yes
Position In Range	67.83
Post Close	29.54
Postmarket Change Percent	1.96
Postmarket Price	$30.12
Ppne	32,000
Price Date	2026-05-08
Ptbv Ratio	3.82
Relative Volume	0.81x
Share Based Comp	22,227,000
Tr6m	-22.3%
Us State	Pennsylvania
Volume	894,870

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MLYS pay a dividend?

Capital-return profile for this ticker.

Performance

MLYS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MLYS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+86.1%

Float: +73.2% of shares outstanding

Insider ownership

+0.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MLYS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.7

Neutral momentum band

Price vs 200-day MA

-5.9%

50/200-day relationship not available

Beta (5Y)

0.48

Less volatile than the market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MLYS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MLYS stock rating?

Mineralys Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MLYS analysis?

The full report lives at /stocks/MLYS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MLYS?

The latest report frames MLYS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MLYS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.